Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
J K Pharmachem Ltd
J K Pharmachem Ltd

J K Pharmachem Ltd (JKPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 400
Jan 04, 2002
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1.90
₹0.10 (5.56%)
1.90Low
Today’s Performance
1.90High
-Low
52 Week’s Performance
1.90High

bt_logoStock Performance

  • No records found!!!

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*-0.30
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-1.31
  • Market Cap (₹ Cr.)*11.28
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
View more

bt_logoFAQ's

What was J K Pharmachem Ltd share price previously?
J K Pharmachem Ltd share price was up by 5.56% from the previous closing price of ₹1.80.
Who are peers of J K Pharmachem Ltd?
The peers of J K Pharmachem Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of J K Pharmachem Ltd?
The promotor/promotors of J K Pharmachem Ltd are Deep Chandra Jain, Kailash Bhansali, Prakash Chandra Jain, Pramod Kapoor, Sudhir A Bidkar, S K Sagar, T S Surendranath, V P Vig, Shweta Girotra.
What has been 52-week high of J K Pharmachem Ltd stocks?
The highest price of J K Pharmachem Ltd stock is ₹0.00 in the last 52-week.
What is the share price of J K Pharmachem Ltd (JKPHARMA) today on NSE?
As on Jan 04, 2002 J K Pharmachem Ltd (JKPHARMA)’s share price on NSE is Rs 1.9
What is the market cap of J K Pharmachem Ltd (JKPHARMA)?
The current market capitalisation of J K Pharmachem Ltd (JKPHARMA) is 11.28 crores
What is J K Pharmachem Ltd Share symbol?
The symbol of J K Pharmachem Ltd is JKPHARMA.
What is the PE ratio of J K Pharmachem Ltd (JKPHARMA)?
The current PE ratio of J K Pharmachem Ltd (JKPHARMA) is -.
What is the PB ratio of J K Pharmachem Ltd (JKPHARMA)?
The current PB ratio of J K Pharmachem Ltd (JKPHARMA) is -0.30.
Today’s High & Low share prices of J K Pharmachem Ltd (JKPHARMA) on NSE?
Today, the share price of J K Pharmachem Ltd (JKPHARMA) on NSE touched a high of Rs 1.899999976158142 and a low of Rs 1.899999976158142
What price did J K Pharmachem Ltd (JKPHARMA) shares open on the NSE today?
On NSE, the share price of J K Pharmachem Ltd (JKPHARMA) opened at Rs 1.899999976158142
What is the 52-week high of J K Pharmachem Ltd (JKPHARMA)?
The 52-week high price of J K Pharmachem Ltd (JKPHARMA) is Rs 1.90
What is the 52-week low of J K Pharmachem Ltd (JKPHARMA)?
The 52-week low price of J K Pharmachem Ltd (JKPHARMA) is Rs -

bt_logoAbout J K Pharmachem

J K Pharmachem Ltd, incorporated in the year 1990, has its registered office in A-7 SIPCOT Industrial Complex, South Arcot Dist Vallalar, Cuddalore, Tamil Nadu, 607005, 91-04142-239016-20, 91-04142-239323. The main industry in which J K Pharmachem Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for J K Pharmachem Ltd is/are Lodha & Co. In the main management, is chairman and Shweta Girotra is the company secretary for J K Pharmachem Ltd.

  • DCJ
    Deep Chandra JainDirector
  • KB
    Kailash BhansaliNominee (UTI)
  • PCJ
    Prakash Chandra JainDirector
  • PK
    Pramod KapoorDirector
  • SAB
    Sudhir A BidkarDirector
  • SKS
    S K SagarDirector
  • TSS
    T S SurendranathNominee (TIDCO)
  • VPV
    V P VigDirector
  • SG
    Shweta GirotraDeputy Company Secretary

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.